Oppenheimer Maintains an 'Outperform' on China Nuokang Bio-Pharmaceutical (NKBP); 3Q11 Review: Lukewarm Quarter But Bumpy Path Ahead
Go back to Oppenheimer Maintains an 'Outperform' on China Nuokang Bio-Pharmaceutical (NKBP); 3Q11 Review: Lukewarm Quarter But Bumpy Path Ahead| CHINA NUOKANG SPADR (NASDAQ: NKBP) | Delayed: 5.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.54 | 52 Week High | $5.74 | |||
| Open | $5.54 | 52 Week Low | $2.41 | |||
| Day High | $5.54 | P/E | N/A | |||
| Day Low | $5.54 | EPS | $0.00 | |||
| Volume | 11,725 | |||||
